nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—coronary artery disease—metabolic syndrome X	0.976	1	CtDrD
Ticagrelor—P2RY12—artery—metabolic syndrome X	0.00487	0.592	CbGeAlD
Ticagrelor—P2RY12—cardiovascular system—metabolic syndrome X	0.00169	0.206	CbGeAlD
Ticagrelor—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.000699	0.0479	CbGpPWpGaD
Ticagrelor—P2RY12—Signal amplification—PLA2G4A—metabolic syndrome X	0.000649	0.0444	CbGpPWpGaD
Ticagrelor—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.000618	0.0423	CbGpPWpGaD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000543	0.0372	CbGpPWpGaD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000497	0.034	CbGpPWpGaD
Ticagrelor—ABCB1—blood vessel—metabolic syndrome X	0.000466	0.0567	CbGeAlD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000426	0.0292	CbGpPWpGaD
Ticagrelor—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.000419	0.0287	CbGpPWpGaD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000335	0.0229	CbGpPWpGaD
Ticagrelor—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000328	0.0224	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000312	0.0214	CbGpPWpGaD
Ticagrelor—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.00031	0.0212	CbGpPWpGaD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000306	0.021	CbGpPWpGaD
Ticagrelor—CYP3A4—kidney—metabolic syndrome X	0.000288	0.035	CbGeAlD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000285	0.0195	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000263	0.018	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.000238	0.0163	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.000221	0.0151	CbGpPWpGaD
Ticagrelor—ABCB1—cardiovascular system—metabolic syndrome X	0.000208	0.0253	CbGeAlD
Ticagrelor—ABCB1—kidney—metabolic syndrome X	0.000204	0.0248	CbGeAlD
Ticagrelor—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000202	0.0138	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000192	0.0132	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000189	0.0129	CbGpPWpGaD
Ticagrelor—ABCB1—adipose tissue—metabolic syndrome X	0.000183	0.0223	CbGeAlD
Ticagrelor—CYP3A4—liver—metabolic syndrome X	0.000182	0.0221	CbGeAlD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000176	0.012	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000172	0.0118	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.000166	0.0114	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000164	0.0112	CbGpPWpGaD
Ticagrelor—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.000156	0.0107	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000154	0.0106	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000147	0.0101	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000147	0.01	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000144	0.00985	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IGF2—metabolic syndrome X	0.000143	0.00977	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00014	0.00955	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PLA2G4A—metabolic syndrome X	0.000135	0.00923	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000132	0.00905	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000129	0.00882	CbGpPWpGaD
Ticagrelor—ABCB1—liver—metabolic syndrome X	0.000129	0.0157	CbGeAlD
Ticagrelor—Contusion—Metformin—metabolic syndrome X	0.000128	0.081	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—CD36—metabolic syndrome X	0.000126	0.00861	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	0.000124	0.00849	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000114	0.00778	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000112	0.00768	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—APOA1—metabolic syndrome X	0.00011	0.00751	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000108	0.00738	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—GHRL—metabolic syndrome X	0.000106	0.00728	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000102	0.00701	CbGpPWpGaD
Ticagrelor—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.000102	0.00697	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000101	0.00691	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CNR1—metabolic syndrome X	0.000101	0.00689	CbGpPWpGaD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	9.39e-05	0.00643	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	9.17e-05	0.00627	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	8.7e-05	0.00596	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ALB—metabolic syndrome X	8.69e-05	0.00595	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	8.57e-05	0.00587	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—MTNR1B—metabolic syndrome X	8.13e-05	0.00557	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL5—metabolic syndrome X	7.8e-05	0.00534	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	7.78e-05	0.00533	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	7.68e-05	0.00525	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MTNR1B—metabolic syndrome X	7.39e-05	0.00506	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IGF2—metabolic syndrome X	7.36e-05	0.00504	CbGpPWpGaD
Ticagrelor—Breast disorder—Metformin—metabolic syndrome X	7.32e-05	0.0463	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—APOB—metabolic syndrome X	7.14e-05	0.00489	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	7.06e-05	0.00483	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	7e-05	0.00479	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PLA2G4A—metabolic syndrome X	6.95e-05	0.00476	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	6.84e-05	0.00468	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—AGT—metabolic syndrome X	6.53e-05	0.00447	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CD36—metabolic syndrome X	6.48e-05	0.00444	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	6.34e-05	0.00434	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—HTR2C—metabolic syndrome X	6.34e-05	0.00434	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GHRL—metabolic syndrome X	6.01e-05	0.00411	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	5.79e-05	0.00396	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HTR2C—metabolic syndrome X	5.75e-05	0.00394	CbGpPWpGaD
Ticagrelor—Bradycardia—Metformin—metabolic syndrome X	5.71e-05	0.0361	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CNR1—metabolic syndrome X	5.69e-05	0.00389	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—APOA1—metabolic syndrome X	5.65e-05	0.00387	CbGpPWpGaD
Ticagrelor—Oedema peripheral—Metformin—metabolic syndrome X	5.52e-05	0.035	CcSEcCtD
Ticagrelor—Connective tissue disorder—Metformin—metabolic syndrome X	5.51e-05	0.0349	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	5.5e-05	0.00376	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GHRL—metabolic syndrome X	5.45e-05	0.00373	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL2—metabolic syndrome X	5.37e-05	0.00368	CbGpPWpGaD
Ticagrelor—Eye disorder—Metformin—metabolic syndrome X	5.24e-05	0.0332	CcSEcCtD
Ticagrelor—Cardiac disorder—Metformin—metabolic syndrome X	5.2e-05	0.0329	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CNR1—metabolic syndrome X	5.17e-05	0.00354	CbGpPWpGaD
Ticagrelor—Angiopathy—Metformin—metabolic syndrome X	5.09e-05	0.0322	CcSEcCtD
Ticagrelor—Immune system disorder—Metformin—metabolic syndrome X	5.06e-05	0.032	CcSEcCtD
Ticagrelor—Mediastinal disorder—Metformin—metabolic syndrome X	5.05e-05	0.032	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	4.98e-05	0.00341	CbGpPWpGaD
Ticagrelor—Malnutrition—Metformin—metabolic syndrome X	4.88e-05	0.0309	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—HDAC3—metabolic syndrome X	4.88e-05	0.00334	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IGF1—metabolic syndrome X	4.72e-05	0.00323	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SERPINE1—metabolic syndrome X	4.49e-05	0.00307	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—metabolic syndrome X	4.48e-05	0.00307	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCL5—metabolic syndrome X	4.41e-05	0.00302	CbGpPWpGaD
Ticagrelor—Syncope—Metformin—metabolic syndrome X	4.38e-05	0.0277	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—MTNR1B—metabolic syndrome X	4.36e-05	0.00299	CbGpPWpGaD
Ticagrelor—Loss of consciousness—Metformin—metabolic syndrome X	4.29e-05	0.0271	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—NOS3—metabolic syndrome X	4.28e-05	0.00293	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TRIB3—metabolic syndrome X	4.25e-05	0.00291	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RBP4—metabolic syndrome X	4.25e-05	0.00291	CbGpPWpGaD
Ticagrelor—Hypertension—Metformin—metabolic syndrome X	4.21e-05	0.0267	CcSEcCtD
Ticagrelor—Chest pain—Metformin—metabolic syndrome X	4.16e-05	0.0263	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	4.13e-05	0.0261	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CCL5—metabolic syndrome X	4e-05	0.00274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.99e-05	0.00273	CbGpPWpGaD
Ticagrelor—Shock—Metformin—metabolic syndrome X	3.92e-05	0.0248	CcSEcCtD
Ticagrelor—Nervous system disorder—Metformin—metabolic syndrome X	3.91e-05	0.0247	CcSEcCtD
Ticagrelor—Skin disorder—Metformin—metabolic syndrome X	3.87e-05	0.0245	CcSEcCtD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	3.87e-05	0.00265	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	3.82e-05	0.00261	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOC3—metabolic syndrome X	3.77e-05	0.00258	CbGpPWpGaD
Ticagrelor—Hypotension—Metformin—metabolic syndrome X	3.72e-05	0.0236	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—AGT—metabolic syndrome X	3.69e-05	0.00252	CbGpPWpGaD
Ticagrelor—Paraesthesia—Metformin—metabolic syndrome X	3.58e-05	0.0226	CcSEcCtD
Ticagrelor—Dyspnoea—Metformin—metabolic syndrome X	3.55e-05	0.0225	CcSEcCtD
Ticagrelor—Dyspepsia—Metformin—metabolic syndrome X	3.51e-05	0.0222	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Metformin—metabolic syndrome X	3.44e-05	0.0218	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	3.44e-05	0.00235	CbGpPWpGaD
Ticagrelor—Fatigue—Metformin—metabolic syndrome X	3.43e-05	0.0217	CcSEcCtD
Ticagrelor—Constipation—Metformin—metabolic syndrome X	3.41e-05	0.0216	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—HTR2C—metabolic syndrome X	3.4e-05	0.00233	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGT—metabolic syndrome X	3.35e-05	0.00229	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	3.3e-05	0.00226	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CYBA—metabolic syndrome X	3.29e-05	0.00225	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Metformin—metabolic syndrome X	3.28e-05	0.0208	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Metformin—metabolic syndrome X	3.26e-05	0.0206	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—GHRL—metabolic syndrome X	3.22e-05	0.00221	CbGpPWpGaD
Ticagrelor—Abdominal pain—Metformin—metabolic syndrome X	3.15e-05	0.0199	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CNR1—metabolic syndrome X	3.05e-05	0.00209	CbGpPWpGaD
Ticagrelor—Asthenia—Metformin—metabolic syndrome X	2.86e-05	0.0181	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—TGFB1—metabolic syndrome X	2.83e-05	0.00194	CbGpPWpGaD
Ticagrelor—Pruritus—Metformin—metabolic syndrome X	2.82e-05	0.0178	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—metabolic syndrome X	2.76e-05	0.00189	CbGpPWpGaD
Ticagrelor—Diarrhoea—Metformin—metabolic syndrome X	2.73e-05	0.0172	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	2.72e-05	0.00186	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	2.67e-05	0.00183	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	2.65e-05	0.00181	CbGpPWpGaD
Ticagrelor—Dizziness—Metformin—metabolic syndrome X	2.63e-05	0.0167	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	2.54e-05	0.00174	CbGpPWpGaD
Ticagrelor—Vomiting—Metformin—metabolic syndrome X	2.53e-05	0.016	CcSEcCtD
Ticagrelor—Rash—Metformin—metabolic syndrome X	2.51e-05	0.0159	CcSEcCtD
Ticagrelor—Dermatitis—Metformin—metabolic syndrome X	2.51e-05	0.0159	CcSEcCtD
Ticagrelor—Headache—Metformin—metabolic syndrome X	2.5e-05	0.0158	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—IGF2—metabolic syndrome X	2.49e-05	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOB—metabolic syndrome X	2.42e-05	0.00166	CbGpPWpGaD
Ticagrelor—Nausea—Metformin—metabolic syndrome X	2.37e-05	0.015	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CCL5—metabolic syndrome X	2.37e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.36e-05	0.00161	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LPL—metabolic syndrome X	2.31e-05	0.00158	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	2.24e-05	0.00153	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	2.18e-05	0.0015	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FMO3—metabolic syndrome X	2.16e-05	0.00148	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	2.1e-05	0.00144	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	2.03e-05	0.00139	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGT—metabolic syndrome X	1.98e-05	0.00135	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—metabolic syndrome X	1.97e-05	0.00135	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—metabolic syndrome X	1.94e-05	0.00133	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOE—metabolic syndrome X	1.94e-05	0.00133	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—EPHX2—metabolic syndrome X	1.93e-05	0.00132	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	1.93e-05	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA1—metabolic syndrome X	1.92e-05	0.00131	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	1.86e-05	0.00127	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—G6PC2—metabolic syndrome X	1.81e-05	0.00124	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRS1—metabolic syndrome X	1.73e-05	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INS—metabolic syndrome X	1.66e-05	0.00113	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.64e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—metabolic syndrome X	1.63e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—metabolic syndrome X	1.6e-05	0.0011	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FABP4—metabolic syndrome X	1.54e-05	0.00105	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—metabolic syndrome X	1.52e-05	0.00104	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	1.46e-05	0.000999	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—metabolic syndrome X	1.45e-05	0.000994	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.35e-05	0.000921	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	1.34e-05	0.000919	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FMO3—metabolic syndrome X	1.33e-05	0.000911	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—G6PD—metabolic syndrome X	1.3e-05	0.00089	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HDAC3—metabolic syndrome X	1.27e-05	0.000869	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	1.25e-05	0.000858	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—metabolic syndrome X	1.24e-05	0.000852	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCKR—metabolic syndrome X	1.24e-05	0.000849	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPA—metabolic syndrome X	1.24e-05	0.000849	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—metabolic syndrome X	1.22e-05	0.000839	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	1.2e-05	0.000823	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA5—metabolic syndrome X	1.19e-05	0.000814	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	1.19e-05	0.000812	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	1.19e-05	0.000812	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.13e-05	0.000777	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—metabolic syndrome X	1.13e-05	0.000774	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	1.12e-05	0.000763	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TRIB3—metabolic syndrome X	1.11e-05	0.000757	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.06e-05	0.000728	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NAMPT—metabolic syndrome X	9.92e-06	0.000679	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LIPC—metabolic syndrome X	9.86e-06	0.000675	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCK—metabolic syndrome X	9.86e-06	0.000675	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOC3—metabolic syndrome X	9.8e-06	0.000671	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—metabolic syndrome X	9.6e-06	0.000657	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CETP—metabolic syndrome X	9.51e-06	0.000651	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FABP4—metabolic syndrome X	9.48e-06	0.000649	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	9.34e-06	0.000639	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SCARB1—metabolic syndrome X	9.11e-06	0.000623	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	8.99e-06	0.000615	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SREBF1—metabolic syndrome X	8.84e-06	0.000605	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMGCR—metabolic syndrome X	8.6e-06	0.000589	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GOT2—metabolic syndrome X	8.6e-06	0.000589	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	8.43e-06	0.000577	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—G6PD—metabolic syndrome X	8.01e-06	0.000549	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	7.82e-06	0.000535	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCA1—metabolic syndrome X	7.67e-06	0.000525	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	7.67e-06	0.000525	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPA—metabolic syndrome X	7.64e-06	0.000523	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCKR—metabolic syndrome X	7.64e-06	0.000523	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GOT1—metabolic syndrome X	7.42e-06	0.000508	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GGT1—metabolic syndrome X	7.42e-06	0.000508	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	7.4e-06	0.000507	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA5—metabolic syndrome X	7.33e-06	0.000502	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—metabolic syndrome X	7.24e-06	0.000495	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	6.81e-06	0.000466	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—metabolic syndrome X	6.68e-06	0.000457	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOB—metabolic syndrome X	6.3e-06	0.000431	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	6.13e-06	0.000419	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.11e-06	0.000418	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.07e-06	0.000416	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.07e-06	0.000416	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.04e-06	0.000413	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPL—metabolic syndrome X	6.02e-06	0.000412	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.86e-06	0.000401	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CD36—metabolic syndrome X	5.72e-06	0.000391	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.61e-06	0.000384	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.45e-06	0.000373	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARA—metabolic syndrome X	5.31e-06	0.000364	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GOT2—metabolic syndrome X	5.3e-06	0.000363	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	5.3e-06	0.000363	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AGT—metabolic syndrome X	5.15e-06	0.000352	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOE—metabolic syndrome X	5.04e-06	0.000345	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA1—metabolic syndrome X	4.98e-06	0.000341	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.72e-06	0.000323	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.72e-06	0.000323	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.57e-06	0.000313	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.57e-06	0.000313	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.39e-06	0.000301	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—INS—metabolic syndrome X	4.31e-06	0.000295	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—metabolic syndrome X	3.95e-06	0.00027	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.88e-06	0.000266	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.78e-06	0.000259	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.78e-06	0.000258	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.71e-06	0.000254	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.52e-06	0.000241	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.45e-06	0.000236	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.27e-06	0.000224	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.17e-06	0.000217	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.11e-06	0.000213	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.07e-06	0.00021	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.71e-06	0.000185	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—INS—metabolic syndrome X	2.65e-06	0.000182	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.43e-06	0.000167	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.33e-06	0.000159	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.13e-06	0.000146	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.74e-06	0.000119	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.07e-06	7.32e-05	CbGpPWpGaD
